Inflammopharmacology

Inflammopharmacology

炎症药理学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Inflammopharmacology》是由Springer International Publishing出版社于1991年创办的英文国际期刊(ISSN: 0925-4692,E-ISSN: 1568-5608),该期刊长期致力于毒理学领域的创新研究,主要研究方向为IMMUNOLOGYTOXICOLOGY-TOXICOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0576...%),以发表毒理学领域等方向的原创性研究为核心(研究类文章占比65.78%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在263篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Inflammopharmacology审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约263篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 263 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
TOXICOLOGY 毒理学 IMMUNOLOGY 免疫学
1区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学 TOXICOLOGY 毒理学
2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q2 56 / 181

69.3%

学科:TOXICOLOGY SCIE Q1 17 / 106

84.4%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 37 / 181

79.83%

学科:TOXICOLOGY SCIE Q1 17 / 106

84.43%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:8 SJR:0.952 SNIP:1.006
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q1 37 / 272

86%

大类:Medicine 小类:Pharmacology Q1 70 / 313

77%

大类:Medicine 小类:Immunology Q2 80 / 236

66%

期刊发文

  • Diosmetin alleviates acute lung injury caused by lipopolysaccharide by targeting barrier function

    Author: Xia, Jiying; Li, Junhong; Deng, Mengsheng; Yin, Fei; Liu, Jianhui; Wang, Jianmin

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01228-7

  • Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases

    Author: Zhou, Peng; Ma, Yao-yao; Zhao, Xiao-ni; Hua, Fang

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-022-01130-8

  • Inhibition of STAT3 phosphorylation by colchicine regulates NLRP3 activation to alleviate sepsis-induced acute lung injury

    Author: Liu, Yuanshui; Yang, Hang; Zhu, Fei; Ouyang, Yanhong; Pan, Pinhua

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01199-9

  • Adalimumab combined with erythropoietin improves recovery from spinal cord injury by suppressing microglial M1 polarization-mediated neural inflammation and apoptosis

    Author: Liu, Yanming; Zhang, Feiyue; Sun, Qi; Liang, Lichao

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. 31, Issue 2, pp. 887-897. DOI: 10.1007/s10787-022-01090-z

  • Suprabasin-derived polypeptides: SBSN(50-63) induces inflammatory response via TLR4-mediated mast cell activation

    Author: Zhou, Tong; Du, Xueshan; Zhang, Lei; Zheng, Yi; Jia, Tao; Song, Xiangjin; Che, Delu; Geng, Songmei

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01137-9

  • Synovial mesenchymal stem cell-derived exosomal microRNA-320c facilitates cartilage damage repair by targeting ADAM19-dependent Wnt signalling in osteoarthritis rats

    Author: Kong, Ruina; Zhang, Ju; Ji, Lianmei; Yu, Yiyi; Gao, Jie; Zhao, Dongbao

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. 31, Issue 2, pp. 915-926. DOI: 10.1007/s10787-023-01142-y

  • A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis

    Author: Guo, Haohao; Wang, Ziyang; Ma, Runsheng; Chen, Xin; Li, Hongqiang; Tang, Yifeng; Du, Gongbo; Zhang, Yifei; Yin, Detao

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. 31, Issue 2, pp. 745-754. DOI: 10.1007/s10787-023-01148-6

  • Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of Nrf2/HO-1 signaling

    Author: Zafar, Sana; Luo, Yong; Zhang, Li; Li, Chang Hu; Khan, Adnan; Khan, Muhammad Ibrar; Shah, Kifayatullah; Seo, Eun Kyoung; Wang, Feng; Khan, Salman

    Journal: INFLAMMOPHARMACOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10787-023-01225-w